BostonGene helps drug developers de-risk and accelerate R&D with a clinically validated AI platform built for oncology and supported by a CLIA-certified, CAP-accredited lab. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights to inform trial design, optimize patient selection, and improve outcomes. Our solutions are used in clinical settings to personalize care and guide therapy decisions for patients.